Merck was late to join the race to develop a vaccine to protect against the virus, which is again surging in many parts of the world in...

Matthew Loflin was coughing up blood, struggling to breathe and losing consciousness in his cell while awaiting trial on drug-possessio...

(Reuters) – On Wednesday, Drugmaker Biogen Inc < BIIB.O > lowers its earnings outlook to 2020 and predicts its Tecfidera drug blockbust...

Diners at the Wausau restuarant, Wis., 15 Oct. 2020. Oct. (The New York Times) (Gabriela Bhaskar) CHICAGO — When the coronavirus starte...

NEW DELHI (Reuters) — Once regulatory approvals are issued, Sanitary Minister Harsh Vardhan said that the Serum Institute for India and...

"The American people do not panic," Biden said. "Trump panicked."

By Carl O'Donnell and Michael Erman (Reuters) – The government-sponsored clinical trial of the antibodies COVID-19, identical to one ta...

The drugmaker said its two-antibody cocktail helped reduce viral levels more than the single antibody treatment had in a prior study....